Medical research

NOX4 implicated in fibrosis

Genkyotex, a developer of selective NOX enzyme inhibitors, announced today the publication of data showing that GKT137831, a first in class NOX1 and 4 inhibitor, was able to reverse lung fibrosis associated with aging in ...

Diseases, Conditions, Syndromes

Two deaths, six new MERS virus cases in Saudi: WHO

Eight new cases of the deadly coronavirus MERS, a SARS-like infection, have been registered in Saudi Arabia, the World Health Organisation said on Wednesday.

Diseases, Conditions, Syndromes

Cell response to new coronavirus unveils possible paths to treatments

NIH-supported scientists used lab-grown human lung cells to study the cells' response to infection by a novel human coronavirus (called nCoV) and compiled information about which genes are significantly disrupted in early ...

Medical research

Breakthrough could help sufferers of fatal lung disease

Pioneering research conducted by the University of Sheffield is paving the way for new treatments which could benefit patients suffering from the fatal lung disease pulmonary arterial hypertension (PAH).

Diseases, Conditions, Syndromes

Lung disease sufferers falling 'under the radar'

South Australians suffering from the most common fatal lung disease face an ongoing struggle with health services, according to new research from the University of Adelaide.

Medical research

Big advance against cystic fibrosis

Harvard stem cell researchers at Massachusetts General Hospital (MGH) have taken a critical step in making possible the discovery in the relatively near future of a drug to control cystic fibrosis (CF), a fatal lung disease ...

page 2 from 3